Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews · Kidney and Transplant

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 3 · 100%High 0 · 0%

T‐cell antibody induction vs no antibody induction

Bronchiolitis obliterans syndrome · lung transplant recipients

T‐cell antibody induction showed no clear difference in bronchiolitis obliterans syndrome compared with no antibody induction (moderate certainty).

1 finding from 1 review

Antibody induction therapy for lung transplant recipients 2013 · Cochrane Headline outcomes only
RR 0.77 [0.55, 1.09]
3 studies · 140 participants
Moderate

Polyclonal T‐cell antibody induction vs interleukin‐2 receptor antagonist induction

Bronchiolitis obliterans syndrome · lung transplant recipients

Polyclonal T‐cell antibody induction showed no clear difference in bronchiolitis obliterans syndrome compared with interleukin‐2 receptor antagonist induction (moderate certainty).

1 finding from 1 review

Antibody induction therapy for lung transplant recipients 2013 · Cochrane Headline outcomes only
RR 1.66 [0.42, 6.53]
2 studies · 76 participants
Moderate

Polyclonal T‐cell antibody vs no antibody induction

Bronchiolitis obliterans syndrome · lung transplant recipients

Polyclonal T‐cell antibody showed no clear difference in bronchiolitis obliterans syndrome compared with no antibody induction (moderate certainty).

1 finding from 1 review

Antibody induction therapy for lung transplant recipients 2013 · Cochrane Headline outcomes only
RR 0.81 [0.57, 1.16]
3 studies · 125 participants
Moderate